Unknown

Dataset Information

0

Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression.


ABSTRACT: Incidences of cardiovascular diseases (CVD) are high among virologically suppressed HIV-infected individuals. Monocyte activation and trafficking are key mechanisms in the evolution of CVD. We studied the ability of cenicriviroc (CVC), a dual C-C chemokine receptor type 2 (CCR2) and CCR5 antagonist, to influence the migration of monocytes from HIV-infected individuals on antiretroviral therapy (ART). Monocytes were derived from 23 ART-suppressed HIV-infected and 16 HIV-uninfected donors. In a trans-endothelial migration model, monocytes, and human aortic endothelial cells (HAoECs) were exposed to cenicriviroc and migrated monocytes, quantified. Expression of CCR2 and CCR5 on monocytes and adhesion molecules (E-selectin, ICAM-1, VCAM-1, PECAM-1, and CD99) on HAoECs were measured. The single antagonists, BMS-22 (CCR2), and maraviroc (CCR5), served as controls. When both HAoECs and monocytes together were exposed to the antagonists, cenicriviroc led to a greater decrease in monocyte migration compared to BMS-22 or vehicle in both HIV-infected and HIV-uninfected groups (P < 0.05), with maraviroc having no inhibitory effect. Cenicriviroc treatment of HAoECs alone decreased monocyte migration in the HIV-infected group when compared to vehicle (P < 0.01). Inhibition of migration was not evident when monocytes alone were exposed to cenicriviroc, BMS-22 or maraviroc. Incubation of HAoECs with cenicriviroc decreased E-selectin expression (P = 0.045) but had limited effects on the other adhesion molecules. Cenicriviroc inhibits monocyte trans-endothelial migration more effectively than single chemokine receptor blockade, which may be mediated via disruption of monocyte-endothelial tethering through reduced E-selectin expression. Cenicriviroc should be considered as a therapeutic intervention to reduce detrimental monocyte trafficking.

SUBMITTER: D'Antoni ML 

PROVIDER: S-EPMC6258344 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression.

D'Antoni Michelle L ML   Mitchell Brooks I BI   McCurdy Sara S   Byron Mary Margaret MM   Ogata-Arakaki Debra D   Chow Dominic D   Mehta Nehal N NN   Boisvert William A WA   Lefebvre Eric E   Shikuma Cecilia M CM   Ndhlovu Lishomwa C LC   Baumer Yvonne Y  

Journal of leukocyte biology 20180808 6


Incidences of cardiovascular diseases (CVD) are high among virologically suppressed HIV-infected individuals. Monocyte activation and trafficking are key mechanisms in the evolution of CVD. We studied the ability of cenicriviroc (CVC), a dual C-C chemokine receptor type 2 (CCR2) and CCR5 antagonist, to influence the migration of monocytes from HIV-infected individuals on antiretroviral therapy (ART). Monocytes were derived from 23 ART-suppressed HIV-infected and 16 HIV-uninfected donors. In a tr  ...[more]

Similar Datasets

| S-EPMC8581997 | biostudies-literature
| S-EPMC7563923 | biostudies-literature
| S-EPMC3138282 | biostudies-literature
| S-EPMC4376629 | biostudies-literature
| S-EPMC8629865 | biostudies-literature
| S-EPMC3286450 | biostudies-literature
| S-EPMC7317803 | biostudies-literature
| S-EPMC3885237 | biostudies-literature
| S-EPMC5425971 | biostudies-literature
| S-EPMC7392080 | biostudies-literature